| Literature DB >> 28720010 |
Jelena Milic1, Taulant Muka1, M Arfan Ikram1, Oscar H Franco1, Henning Tiemeier1,2,3.
Abstract
OBJECTIVE: We aimed to explore correlates and predictors of bereavement severity and persistence (triggered by "loss of a loved one"; referent group partner loss) in the Rotterdam cohort.Entities:
Keywords: end of life; epidemiology; families; geriatrics; mental health
Mesh:
Year: 2017 PMID: 28720010 PMCID: PMC5680907 DOI: 10.1177/0898264317720715
Source DB: PubMed Journal: J Aging Health ISSN: 0898-2643
Figure 1.Characteristics of study participants: For cross-sectional and longitudinal analyses.
Note. MMSE = Mini-Mental State Examination.
Characteristics of Study Participants: For Cross-Sectional and Longitudinal Analyses.
| Grievers ( | Cessation of grief ( | Continuous grief ( | |
|---|---|---|---|
| Age (years), | 72.6 (7.6) | 70.0 (6.6) | 70.0 (6.4) |
| Gender (female), % | 73 | 73 | 81 |
| Education | |||
| Primary, % | 11 | 6 | 11 |
| Intermediate, % | 76 | 79 | 73 |
| High, % | 13 | 15 | 16 |
| Depressive symptoms score, | 8.8 (8.6) | 7.1 (7.2) | 10.5 (10.9) |
| Activities of daily living problems score, | 0.5 (0.5) | 0.4 (0.4) | 0.5 (0.5) |
| Social support score, | 9.2 (1.4) | 9.3 (1.5) | 9.3 (1.3) |
| Diagnosed MDD, % | 4 | 2 | 8 |
| Who died? | |||
| Partner (reference), % | 50 | 56 | 45 |
| Child, % | 11 | 9 | 14 |
| Other, % | 39 | 36 | 41 |
| Psycholeptics[ | 20 | 14 | 24 |
Note. Values are presented as mean (SD) or percentage. MDD = major depressive disorder.
Psycholeptics includes benzodiazepines, antidepressants, neuroleptics, and anticonvulsants.
Factors Associated With Grief Severity: Cross-Sectional Analysis Grief Severity at the Baseline–ICG Score.
| Factors | Model 1[ | Model 2[ | ||||
|---|---|---|---|---|---|---|
|
| 95% CI |
|
| 95% CI |
| |
| Gender (female) | 0.35 | [−1.30, 2.00] | .68 | 1.94 | [0.35, 3.52] |
|
| Age, per year increase | 0.07 | [−0.02, 0.17] | .13 | −0.06 | [−0.16, 0.04] | .24 |
| Grief severity at the baseline, per unit increase | ||||||
| Social support, per unit increase | −0.70 | [−1.23, −0.18] |
| −0.28 | [−0.72, 0.26] | .36 |
| Who died? | ||||||
| Partner (reference), % | reference | — | — | reference | — | — |
| Child, % | 2.44 | [−0.01, 4.90] | .05 | 4.24 | [1.91, 6.58] |
|
| Other, % | −5.32 | [−6.88, −3.76] |
| −3.56 | [−5.07, −2.04] |
|
| Depressive symptoms, per 1 point of score | 0.48 | [0.40, 0.56] |
| 0.46 | [0.37, 0.55] |
|
| Education | ||||||
| High (reference), % | reference | — | — | reference | — | — |
| Middle, % | 3.21 | [0.91, 5.50] |
| 3.14 | [1.04, 5.23] |
|
| Primary, % | 5.07 | [1.89, 8.26] |
| 4.81 | [1.89, 7.73] |
|
| Activities of daily living problems, score | 0.19 | [−1.34, 1.73] | .80 | −2.20 | [−3.69, −0.71] |
|
| Psycholeptics[ | −3.70 | [−5.58, −1.81] | ≤ | 0.83 | [−0.96, 2.63] | .36 |
| Comorbidities,[ | 0.49 | [−1.03, 2.01] | .53 | 0.02 | [−1.40, 1.44] | .98 |
| Cognitive functioning, MMSE, score | −0.66 | [−1.27,−0.06] |
| −0.30 | [−0.86, 0.26] | .30 |
Note. CI = confidence interval; ICG = Interview of Complicated Grief; MMSE = The Mini-Mental State Examination test for cognitive impairment.
Model 1 was adjusted for gender and age for each covariate.
Model 2 was adjusted for all listed covariates.
Psycholeptics includes benzodiazepines, antidepressants, neuroleptics, and anticonvulsants.
Comorbidities includes the prevalence of myocardial infarction, heart failure, stroke, joint problems that include osteoarthritis, rheumatoid arthritis gout, back pain and ankylosing spondylitis, chronic obstructive pulmonary disease, and diabetes mellitus.
Bolded values represent all significant associations with P ≤ 0.05
Factors Associated With Grief Persistence: A 6-Year Longitudinal Analysis.
| Factors | Model 1[ | Model 2[ | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| |
| Gender (female) | 0.64 | [0.39, 1.06] | .08 | 0.67 | [0.39, 1.20] | .18 |
| Age, per year increase | 0.99 | [0.96, 1.02] | 0.62 | 0.98 | [0.95, 1.02] | .39 |
| Social support, per unit increase | 1.12 | [0.94, 1.34] | .20 | 1.19 | [0.98, 1.44] | .08 |
| Who died? | ||||||
| Partner (reference), % | reference | — | — | reference | — | — |
| Child, % | 1.22 | [0.61, 2.42] | .57 | 1.40 | [0.67, 2.92] | .65 |
| Other, % | 1.00 | [0.61, 1.63] | .99 | 1.13 | [0.67, 1.91] | .37 |
| Depressive symptoms,[ | 1.02 | [0.99, 1.04] |
| 1.02 | [0.99, 1.06] | .13 |
| Education | ||||||
| High (reference), % | reference | — | — | reference | — | — |
| Middle, % | 0.67 | [0.36, 1.23] | .20 | 0.72 | [0.38, 1.36] | .31 |
| Primary, % | 1.23 | [0.49, 3.08] | .66 | 1.47 | [0.56, 3.88] | .44 |
| Activities of daily living problems, score | 1.11 | [0.69, 1.81] | .66 | 0.90 | [0.52, 1.56] | .70 |
| Psycholeptics[ | 0.73 | [0.42, 1.24] | .24 | 1.25 | [0.69, 2.28] | .46 |
| Comorbidities,[ | 1.41 | [0.92, 2.16] | .11 | 1.45 | [0.91, 2.29] | .12 |
| Cognitive functioning, MMSE, score | 1.08 | [0.90, 1.28] | .41 | 1.08 | [0.90, 1.30] | .41 |
| Baseline value of ICG, score | 1.06 | [1.04, 1.08] |
| 1.05 | [1.03, 1.08] |
|
Note. Grief persisted in 141 of 475 participants; 334 persons reported no grief at follow-up (reference category). OR = odds ratio; CI = confidence interval; MMSE = The Mini-Mental State Examination test for cognitive impairment; ICG = Interview of Complicated Grief.
Model 1 was adjusted for gender and age per covariant.
Model 2 was adjusted for all listed covariates.
Psycholeptics includes benzodiazepines, antidepressants, neuroleptics, and anticonvulsants.
Comorbidities includes the prevalence of myocardial infarction, heart failure, stroke, joint problems that include osteoarthritis, rheumatoid arthritis gout, back pain and ankylosing spondylitis, chronic obstructive pulmonary disease, and diabetes mellitus.